J&J Discloses Fed. Probes Over Arthritis Drugs, Copayments
Johnson & Johnson disclosed to investors on Monday its Janssen Biotech Inc. is under investigation by the U.S. Department of Justice in connection with a False Claims Act case related to...To view the full article, register now.
Already a subscriber? Click here to view full article